Skip to content
Search

Latest Stories

GOPO® for joint health

pharmacy.biz Staff
By pharmacy.biz StaffMay 22, 2020
pharmacy.biz Staff
See Full Bio

Pharmacists have a key role when it comes to advising customers on options to support their long-term joint health, rather than simply recommending a ‘quick fix’.

GOPO® Joint Health provides a scientifically documented rosehip powder that is made using a specialist process to ensure that the powder retains high levels of the galactolipid GOPO®. Rosehip may play a valuable role in the care of joints and joint tissues. The galactolipid GOPO® has been studied in over 20 scientific trials.

GOPO Joint Health is also rich in Vitamin C which is essential for normal collagen formation, needed by the body for healthy bones and cartilage.

High levels of the galactolipid GOPO® are found only in GOPO® Joint Health.

For more information visit the GOPO® Website: www.gopo.co.uk

Or call GR Lanes Health: 01452 524012

Related News

Operation Subaru:
News

12 arrested in MHRA’s biggest medicines trafficking crackdown

Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair
News

Olivier Picard named new NPA chair

RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care
News

Professor Tony Avery OBE awarded RPS Honorary Fellowship

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.
News

Pharma sector needs protecting from Trump tariffs, warn MPs

More For You

Swanley Pharmacy in Kent

Swanley Pharmacy in Kent

First-time buyers swoop in for Allcures Plc's Swanley Pharmacy

A husband and wife couple have embarked on their journey as first time pharmacy owners after buying Swanley Pharmacy in Kent.

Located in Swanley Shopping Centre, the pharmacy dispenses an average of 10,000 items per month.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc